The United States is in a global technology race it can still win, but only if it stops getting in its own way. That’s the message from former Google CEO Eric Schmidt, who frames the contest not as a matter of destiny, but of will. “I want America to win. I am here because of…
Biopharma in Basel builds amid global correction
In the U.S., the biotech sector is navigating a sharp correction. Life sciences lab-space vacancies are above 20% nationally and approach 30% in Greater Boston, with San Diego in the upper-20s. Venture funding has slowed in early 2025. In Greater Boston, there is a record 17 million square feet of available lab space. “The cycles…
Tech’s trillion-dollar tumble and 7 other major R&D moves this week
Welcome to our weekly briefing on R&D headlines for January 27, 2025. In this edition, we cover the disruption from China’s DeepSeek reasoning AI model R1, which punches above its weight class. Ostensibly trained on a shoestring budget, it outperforms OpenAI’s o1 by some measures, according to DeepSeek’s technical report. The company also has publicly…
Where Harris and Trump stand on the future of American science
[Adobe Stock] Updated on October 20, 2024 with new details The current Biden-Harris administration and potential Republican approaches offer different visions for the future of American science. While the Biden-Harris team emphasizes investments in climate change mitigation and clean energy, conservative approaches have historically focused on deregulation and achieving energy independence through traditional energy sources.…
ISS National Lab and NASA partner to accelerate disease research in microgravity
Humanity has long looked to the stars for answers, but why would you want to conduct research in space, especially when it comes to curing diseases here on Earth? The International Space Station (ISS), orbiting roughly 250 miles above us, can help unravel medical mysteries. “The ISS National Lab offers unique opportunities for scientific and…